Skip to main navigation Skip to search Skip to main content

Cardiovascular Pharmacology: An Update and Anesthesia Considerations

  • Camellia Asgarian
  • , Henry Liu
  • , Alan D. Kaye

Research output: Contribution to journalReview articlepeer-review

Abstract

Cardiovascular disease remains a leading cause of morbidity and mortality worldwide. The development of therapeutic agents for the treatment of cardiovascular diseases has always been a priority because of the huge potential market for these drugs. These medications should be part of the anesthesiologist's armamentarium because the typical surgical patient is older and has more comorbidities than in the past. This article reviews commonly used cardiovascular medications that are important in managing patients with unstable hemodynamics.

Original languageEnglish (US)
Pages (from-to)273-284
Number of pages12
JournalAnesthesiology Clinics
Volume35
Issue number2
DOIs
StatePublished - Jun 2017

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

All Science Journal Classification (ASJC) codes

  • Anesthesiology and Pain Medicine

Fingerprint

Dive into the research topics of 'Cardiovascular Pharmacology: An Update and Anesthesia Considerations'. Together they form a unique fingerprint.

Cite this